InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,616.84
(
-0.32%
)
US TECH 100
18,991.20
(
-1.09%
)
Dow Jones
41,240.52
(
0.16%
)
Brent Oil
80.13
(
-0.17%
)
Bitcoin
63,014.14
(
0.22%
)
Post# of 252977
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 837
Posts 120334
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dav1234 post# 164975

Monday, 12/16/2013 9:59:55 AM

Monday, December 16, 2013 9:59:55 AM

Post# of 252977
VRX* acquires SLTM for $2.92/sh in cash:

http://finance.yahoo.com/news/valeant-pharmaceuticals-agrees-acquire-solta-130000891.html

The nominal deal value is $236M, and the buyout price is a 40% premium to Friday’s close.

SLTM has a motley collection of medical devices for cosmetic applications, including the Thermage radio-frequency system for skin tightening (originally owned by THRM) and the Lipisonix “body contouring” system (originally owned by MRX).

*The preeminent biotech “roll-up” company.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up